Define Genetic Counselling & Prenatal Diagnosis. Describe its diagnosis and prevention.
Definition
- Genetic counselling is a communication process that helps a family understand a genetic condition — its diagnosis, natural history, recurrence risk and available options.
- It is non-directive, voluntary and confidential.
Indications
- A previous affected child or a family history of a genetic disorder.
- Consanguinity; advanced maternal age; recurrent pregnancy loss.
- An abnormal antenatal screening test or ultrasound; known carrier status (e.g. Thalassaemia).
Steps in Counselling
Establish an accurate diagnosis → Construct a pedigree → Estimate the recurrence risk (by inheritance pattern) → Communicate risks/options non-directively → Provide ongoing support
Recurrence Risk (examples)
- Autosomal recessive — 25% for two carrier parents.
- Autosomal dominant — 50% if a parent is affected.
- Chromosomal — depends on the type (e.g. Translocation Down syndrome differs from non-disjunction).
Prenatal Screening VS Diagnosis
| Category | Tests |
|---|---|
| Screening (risk estimation) | Maternal serum markers (double/triple/quadruple), first-trimester combined test (NT + PAPP-A + β-hCG), NIPT (cell-free fetal DNA), anomaly ultrasound |
| Diagnostic (definitive) | Chorionic villus sampling (11–14 wk), amniocentesis (15–18 wk), cordocentesis — for karyotype/microarray/molecular tests |
Preventive Options
- Carrier screening and premarital/pre-pregnancy counselling (e.g. Thalassaemia).
- Prenatal diagnosis with informed reproductive choice; preimplantation genetic diagnosis in selected families.
- Folic acid to prevent neural-tube defects; avoidance of teratogens.
Ethical Principles
- Autonomy (the family decides), confidentiality, informed consent and a non-directive stance.
- Sensitivity around reproductive choices and disclosure within families.
Timing of Prenatal Tests
| Test | Timing |
|---|---|
| First-trimester combined screen | 11–14 weeks |
| Chorionic villus sampling | 11–14 weeks |
| Amniocentesis | 15–18 weeks |
| Anomaly ultrasound | 18–20 weeks |
Prevention at Community Level
- Thalassaemia carrier screening and premarital counselling programmes (important in India).
- Periconceptional folic acid; rubella immunisation of girls; avoidance of teratogens/consanguinity awareness.
Nipt — Strengths & Limits
- Non-invasive prenatal testing (cell-free fetal DNA) screens for common trisomies (21, 18, 13) with high sensitivity from ~10 weeks.
- It is a screening test — a positive result must be confirmed by a diagnostic test (CVS/amniocentesis).
Support & Follow-up
Counselling continues after results — supporting the family through decisions, arranging specialist input for an affected pregnancy/child, and planning care and future reproductive options.
Preimplantation Genetic Diagnosis (PGD)
For couples at high risk of a specific single-gene or chromosomal disorder, PGD tests embryos created by IVF before implantation, allowing transfer of unaffected embryos — an option that avoids termination of an established pregnancy.
Carrier-screening Programmes (india)
- Thalassaemia carrier screening with premarital/antenatal counselling has reduced affected births in high-prevalence regions.
- Community education, and rubella immunisation of girls, are complementary preventive measures.
Common Screening Results (interpretation)
- Down syndrome — low PAPP-A, high β-hCG, increased nuchal translucency; low AFP on the quadruple test.
- Neural-tube defects — raised maternal serum AFP and confirmatory ultrasound.
Role in Prevention of Genetic Disease
Together, carrier screening, genetic counselling, prenatal diagnosis and (where appropriate) PGD form a preventive framework that — with folic acid supplementation and teratogen avoidance — reduces the burden of serious genetic and congenital disorders in the community.
All questions in Genetics & Dysmorphology
- Q1Define Down Syndrome. Describe its types, clinical features, diagnosis and management. ★
- Q2Define Turner Syndrome. Describe its clinical features, diagnosis, management and prognosis. ★
- Q3Discuss Patterns of Inheritance — its causes, clinical features and management. ★
- Q4Define Approach to a Dysmorphic Child. Describe its investigations, management and prognosis. ★
- Q5Define Genetic Counselling & Prenatal Diagnosis. Describe its diagnosis and prevention. ★
- SN1Define Klinefelter Syndrome. Describe its clinical features, diagnosis, pathophysiology and prognosis.
- SN2Define Edward (Trisomy 18) & Patau (Trisomy 13) Syndromes. Describe its prognosis and diagnosis.
- SN3Define Fragile X Syndrome. Describe its clinical features, diagnosis, management and prognosis.
- SN4Define Marfan Syndrome. Describe its clinical features, diagnosis and prognosis.
- SN5Define Achondroplasia. Describe its clinical features, management, pathophysiology and prognosis.
- SN6Describe the genomic Imprinting of Prader-Willi & Angelman Syndromes.
- SN7Describe the 22q11.2 Deletion of DiGeorge Syndrome.